We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIFR icon
13851
CALL
Cipher Digital
CIFR
$7.41B
$6.16K ﹤0.01%
11,000
-13,500
-55% -$11.7K
DMK
13852
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6.15K ﹤0.01%
519
-115
-18% -$1.31K
SEEL
13853
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$6.12K ﹤0.01%
2
-56
-97% -$195K
XOS icon
13854
PUT
Xos
XOS
$28.8M
$6.11K ﹤0.01%
460
-73
-14% -$1.88K
CAAP icon
13855
CALL
Corporacion America
CAAP
$6.33B
$6.11K ﹤0.01%
+700
New +$5.67K
MATW icon
13856
CALL
Matthews International
MATW
$725M
$6.09K ﹤0.01%
+200
New +$5.6K
SVFA
13857
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$6.09K ﹤0.01%
+602
New +$6.04K
CPF icon
13858
PUT
Central Pacific Financial
CPF
$996M
$6.08K ﹤0.01%
+300
New +$6.16K
SBIO icon
13859
CALL
ALPS Medical Breakthroughs ETF
SBIO
$215M
$6.08K ﹤0.01%
+200
New +$6.02K
AORT icon
13860
PUT
Artivion
AORT
$1.42B
$6.06K ﹤0.01%
+500
New +$6K
EMX
13861
CALL
DELISTED
EMX Royalty
EMX
$6.05K ﹤0.01%
+3,200
New +$5.87K
ACIC icon
13862
PUT
American Coastal Insurance
ACIC
$466M
$6.04K ﹤0.01%
+5,700
New +$2.73K
NXXT
13863
NextNRG Inc
NXXT
$44.9M
$6.02K ﹤0.01%
+1,114
New +$11.2K
AIIOW
13864
Robo.ai Inc Warrant
AIIOW
$334K
$6K ﹤0.01%
+20,731
New +$6.22K
CRIS icon
13865
PUT
Curis
CRIS
$3.76M
$6K ﹤0.01%
27
-2
-7% -$587
III icon
13866
PUT
Information Services Group
III
$250M
$5.98K ﹤0.01%
1,300
-48,400
-97% -$245K
NTRP icon
13867
NextTrip
NTRP
$21.8M
$5.96K ﹤0.01%
+745
New +$9.32K
GMDA
13868
PUT
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$5.93K ﹤0.01%
+4,600
New +$7.27K
SBLK icon
13869
Star Bulk Carriers
SBLK
$3.24B
$5.92K ﹤0.01%
308
-11,672
-97% -$227K
SIFY
13870
CALL
Sify Technologies
SIFY
$1.13B
$5.92K ﹤0.01%
850
-1,533
-64% -$13.5K
PAVM icon
13871
PUT
PAVmed
PAVM
$37.2M
$5.9K ﹤0.01%
27
-14
-34% -$5.29K
AIRG icon
13872
PUT
Airgain
AIRG
$72.2M
$5.86K ﹤0.01%
+900
New +$6.49K
AXLA
13873
DELISTED
Axcella Health Inc. Common Stock
AXLA
$5.84K ﹤0.01%
713
+261
+58% +$6.76K
ARQ icon
13874
PUT
Arq
ARQ
$102M
$5.83K ﹤0.01%
+2,400
New +$6.53K
SEIC icon
13875
PUT
SEI Investments
SEIC
$12.8B
$5.83K ﹤0.01%
+100
New +$5.62K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.